Back to results
US 2026/0060944 A1Published application
Pharmaceutical composition and use thereof
OwnerKuei-Chung Shihinventor
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition includes: (a) a targeting agent for cancer cell mitochondria, (b) an ion chelating agent, and (c) pharmacologically active multivalent ions. The weight ratio of (a) is 64.5%˜43.7% based on the total weight of the pharmaceutical composition, the weight ratio of (b) is 56.2%˜16.1% based on the total weight of the pharmaceutical composition; the weight ratio of (c) is 19.4%˜0.000116% based on the total weight of the pharmaceutical composition.
Claims10
A pharmaceutical composition, comprising:
- (a) a targeting agent for a mitochondrion of a cancer cell;
- (b) an ion chelating agent;
- and
- (c) a pharmacologically active multivalent ion, wherein the targeting agent for the mitochondrion of the cancer cell is Niclosamide, the ion chelating agent is Disulfiram, and the pharmacologically active multivalent ion is selected from a group consisting of a magnesium ion, a calcium ion, a manganese ion, a ferrous ion, a copper ion, and a zinc ion, and a weight ratio of (a) is 64.5%˜43.7% based on a total weight of the pharmaceutical composition, a weight ratio of (b) is 56.2%˜16.1% based on the total weight of the pharmaceutical composition, and a weight ratio of (c) is 19.4%˜0.000116% based on the total weight of the pharmaceutical composition.
1 more element
Dependencies are inferred from the claim text.